CL.CN
Cresco Labs Inc
Price:  
1.40 
CAD
Volume:  
407,700.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CL.CN EV/EBITDA

279.3%
Upside

As of 2026-02-15, the EV/EBITDA ratio of Cresco Labs Inc (CL.CN) is 9.35. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CL.CN's latest enterprise value is 1,162.54 mil CAD. CL.CN's TTM EBITDA according to its financial statements is 124.35 mil CAD. Dividing these 2 quantities gives us the above CL.CN EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 15.8x - 18.5x 18.4x
Forward P/E multiples 15.5x - 16.1x 16.1x
Fair Price 4.50 - 5.91 5.31
Upside 221.4% - 322.4% 279.3%
1.40 CAD
Stock Price
5.31 CAD
Fair Price

CL.CN EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2026-02-10 8.16
2026-02-09 8.45
2026-02-06 8.27
2026-02-05 8.09
2026-02-04 8.45
2026-02-03 8.30
2026-02-02 8.34
2026-01-30 8.23
2026-01-29 8.20
2026-01-28 8.41
2026-01-27 8.55
2026-01-26 8.94
2026-01-23 9.26
2026-01-22 9.26
2026-01-21 8.98
2026-01-20 9.05
2026-01-19 9.47
2026-01-16 9.54
2026-01-15 9.86
2026-01-14 9.89
2026-01-13 9.65
2026-01-12 10.00
2026-01-09 9.43
2026-01-08 9.40
2026-01-07 9.05
2026-01-06 8.94
2026-01-05 9.01
2026-01-02 9.36
2025-12-31 9.08
2025-12-30 9.05
2025-12-29 8.87
2025-12-24 9.36
2025-12-23 9.05
2025-12-22 8.94
2025-12-19 9.43
2025-12-18 8.98
2025-12-17 12.82
2025-12-16 11.76
2025-12-15 9.43
2025-12-12 10.17
2025-12-11 6.93
2025-12-10 6.96
2025-12-09 7.02
2025-12-08 6.93
2025-12-05 7.14
2025-12-04 7.46
2025-12-03 7.18
2025-12-02 7.32
2025-12-01 7.35
2025-11-28 6.93